GHS-R1a is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2026-05-26. Numbers and descriptions here follow the published literature rather than marketing material.
The molecule contains five residues, including alpha-aminoisobutyric acid, D-2-naphthylalanine, and D-phenylalanine, and it ends in a lysine amide. Non-natural and D-configured residues make the chain less susceptible to common peptidases, which helps explain its resistance to rapid breakdown. Its molecular formula is C38H49N9O5, corresponding to a free-base mass near 711.9 daltons. The C-terminal amide removes a negative charge and is a recurring feature in receptor-active peptides of this family. These structural choices are usually discussed as the basis for its selectivity profile.
Published animal and early human work describes growth hormone release that is separated from comparable rises in adrenocorticotropic hormone and cortisol. Prolactin changes are reported as small in the same studies. Selectivity is attributed to binding at the ghrelin receptor and to the downstream signaling that follows, rather than to differences in how quickly the peptide is cleared. Authors commonly label the compound selective rather than potent, because the same mass produces a smaller growth hormone response than some older secretagogues tested in parallel. Whether that profile holds across species and routes of administration remains an open question.
Published discussion of this compound is uneven. Some references describe it as a tool for probing growth hormone regulation, while others focus on analytical characterization or on comparisons with related secretagogues. Statements about selectivity, half-life and potency often trace back to a small number of original reports that later authors cite secondhand. Readers evaluating a claim should therefore check whether a figure reflects a direct measurement or a repeated citation, and whether the underlying study was conducted in animals, in isolated cells or in human volunteers.
Identity and purity assessment for a research peptide of this kind typically combines reversed-phase high-performance liquid chromatography with mass spectrometry. The chromatographic run separates related impurities and yields a purity percentage, while electrospray ionization or matrix-assisted laser desorption mass spectrometry confirms the expected molecular mass. Amino acid analysis or tandem mass spectrometry sequencing can add confidence when material is intended for quantitative work. Laboratories differ in how they calculate and report purity, so figures from different sources are not always directly comparable.
Lyophilized material is generally stored cold and dry, with desiccant, and protected from light. In solution the peptide is more vulnerable: the histidine side chain can oxidize, and repeated freeze-thaw cycles promote aggregation and loss of material to container surfaces. A mildly acidic aqueous buffer is often used for short-term handling because it limits several degradation routes. Accurate prediction of long-term stability under a given set of conditions is difficult, and published stability data remain sparse.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C38H49N9O5 | Value for the free base |
| Molar mass | 711.9 g/mol | Calculated from the formula |
| Appearance | White to off-white powder | Typical lyophilized form |
| Mechanism class | Ghrelin receptor agonist | Also described as a secretagogue |
| Half-life | About 2 hours | Reported for human circulation |
Reversed-phase high-performance liquid chromatography is the standard tool for assessing purity. Detection near 214 nanometers captures the peptide backbone, and the resulting chromatogram shows the main peak alongside related impurities. Electrospray ionization mass spectrometry confirms molecular mass and supports sequence verification. Common degradation products include oxidized residues, deamidated forms, and truncated fragments, each appearing as a distinct peak or shoulder in the trace.
Quality claims for research peptides vary widely across suppliers. A certificate of analysis should list purity by chromatography, the mass found by spectrometry, and the analytical conditions used. Independent testing at a third-party laboratory is a common way to check identity and purity, because documents alone cannot confirm what is inside a vial. Purity figures describe the proportion of the target peptide among detected species, and they say nothing about biological activity or sterility.
Lyophilized ipamorelin powder is the form usually supplied for laboratory work. Kept dry, protected from light, and held at minus 20 degrees Celsius or below, it remains stable for extended periods, often measured in years. Once dissolved, the peptide degrades faster through hydrolysis, oxidation, and deamidation, so solutions are typically refrigerated and used within weeks. Repeated freeze-thaw cycles and exposure to alkaline conditions accelerate loss of the parent compound.
Structural features distinguish the molecule from earlier secretagogues. An alpha-aminoisobutyric acid residue near the N-terminus and a D-naphthylalanine substitution increase receptor affinity, while C-terminal amidation improves resistance to exopeptidases. These modifications are associated with reduced stimulation of appetite and of the hypothalamic-pituitary-adrenal axis compared with hexarelin or growth hormone releasing peptide-6. Whether the same profile applies at every dose level studied is a matter of ongoing investigation rather than settled consensus.
Ipamorelin is a synthetic pentapeptide that acts as an agonist at the ghrelin receptor, also called the growth hormone secretagogue receptor type 1a. Its sequence incorporates non-natural residues, which slows enzymatic breakdown relative to short native peptides. In laboratory and early clinical work the compound is described as a selective growth hormone secretagogue because it raises growth hormone with comparatively little effect on other pituitary outputs. The degree to which that selectivity holds across species and dosing regimens remains an open question in the published literature.
Most published work on ipamorelin comes from rodent studies and small early-phase human trials. Subcutaneous and intravenous routes have been used, while oral delivery is limited by poor absorption and rapid breakdown in the gut. The reported plasma half-life is short, on the order of two hours, and varies with species and assay method. Whether chronic use produces meaningful clinical benefit remains unresolved, and long-term safety data in humans are sparse. No major regulatory agency has approved the compound as a therapeutic drug.
Ipamorelin is a synthetic pentapeptide that belongs to the growth hormone secretagogue family. Its sequence is Aib-His-D-2-Nal-D-Phe-Lys-NH2, incorporating two non-natural residues that resist enzymatic breakdown. Researchers at Novo Nordisk described the compound in the 1990s while searching for agents that release growth hormone with fewer side effects than earlier secretagogues. The molecule acts as an agonist at the ghrelin receptor, also called GHS-R1a, which is expressed in the pituitary and in several peripheral tissues.
== Treatment == By definition, TIAs are transient, self-resolving, and do not cause permanent impairment. However, they are associated with an increased risk of subsequent ischemic strokes, which can be permanently disabling. Therefore, management centers on the prevention of future ischemic strokes and addressing any modifiable risk factors. The optimal regimen depends on the underlying cause of the TIA.
=== Natural Resource Group === In 1975, the Natural Resources Group of W.R. Grace created the oil and gas contract drilling company of TRG Drilling Corporation. The new corporation started with three oil rigs were previously owned by Amini Oil and Magness Petroleum. In 1978, the Natural Resources Group announced that it will be combining the three oil companies owned by the company into Grace Petroleum Corporation. In 1982, Grace announced that it was creating Grace Drilling Company of Oklahoma which would consolidate what was at that time its six drilling contractors into one company. The units had previously operated as part of the TRG Drilling Corporation and had generated $253 in sales revenue in 1981. The consolidation, the company said, would make it the largest land drilling operations contractor in the Lower 48 with 116 wells.
Nick Fury: Agent of S.H.I.E.L.D. (stylized as Nick Fury: Agent of SHIELD and Nick Fury: Agent of Shield) is a 1998 American television superhero film based on the Marvel Comics character Nick Fury. It was first broadcast on May 26, 1998, on Fox, intended to be a backdoor pilot for a possible new TV series. Written by David Goyer, and directed by Rod Hardy, the film had a $6 million production budget. It stars David Hasselhoff as Fury, a retired super spy who is approached to return to duty to take down the terrorist organization HYDRA, who threaten to attack Manhattan with a pathogen they have reconstituted known as the Death's Head virus. Lisa Rinna plays Contessa Valentina "Val" Allegra de Fontaine, and Sandra Hess plays Andrea von Strucker/Viper. It was released on DVD on September 30, 2008. The film was met with a largely negative reception.
22789Ac α (1.38%)→21.77 y 22387Fr β−→22 min 22388Ra α→11.4 d21986Rn The next element below francium (eka-francium) in the periodic table would be ununennium (Uue), element 119. The synthesis of ununennium was first attempted in 1985 by bombarding a target of einsteinium-254 with calcium-48 ions at the superHILAC accelerator at the Lawrence Berkeley National Laboratory in Berkeley, California. No atoms were identified, leading to a limiting yield of 300 nb.
=== Cold mixed absinthe === Many modern absinthes are produced using a cold-mix process. This inexpensive method of production does not involve distillation, and is regarded as inferior for the same reasons that give cause for cheaply compounded gin to be legally differentiated from distilled gin. The cold mixing process involves the simple blending of flavouring essences and artificial colouring in commercial alcohol, in similar fashion to most flavoured vodkas and inexpensive liqueurs and cordials. Some modern cold-mixed absinthes have been bottled at strengths approaching 90% ABV. Others are presented simply as a bottle of plain alcohol with a small amount of powdered herbs suspended within it. The lack of a formal legal definition in most countries to regulate the production and quality of absinthe has enabled cheaply made products to be falsely presented as traditional in production and composition. In Switzerland, the only country with a formal legal definition of absinthe, any absinthe product not obtained by maceration and distillation or coloured artificially cannot be sold as absinthe.
Sources: en.wikipedia.org
=== Inhibin === In both females and males, inhibin inhibits FSH production. Inhibin does not inhibit the secretion of GnRH from the hypothalamus. However, the overall mechanism differs between the sexes:
== See also == Ketoconazole, another antifungal agent used in shampoos Piroctone olamine, another antifungal agent used in shampoos Selenium disulfide, an active ingredient used in shampoos such as Selsun Blue
Wingstop opened its first international restaurant in Mexico in 2010. In April 2013, Wingstop announced that they are opening the first store in Southeast Asia, starting in Singapore. In February 2014, Wingstop announced the opening of stores in the Philippines. The first Philippine store opened in June 2014. In the same month, plans were announced for Wingstop to open in Indonesia with 100 stores by 2021. Franchises began opening in London, UK in 2018 and have now grown to 20 locations in the Greater London area. Originally introduced to England by Lemon Pepper Holdings, the majority stakeholder in the franchise is now Sixth Street Partners - the same investment firm that owns the Far West Services franchises on the US West Coast. In 2021, Wingstop made an agreement with JPK Capital to develop 100 Wingstop locations in Canada. The first restaurant in Canada opened in June 2022. In May 2022, Wingstop announced plans to enter South Korea. As of November 26, 2025, Wingstop operates in 15 countries internationally. Recent expansions include Australia, Bahrain, Kuwait, Puerto Rico, Saudi Arabia, and the Netherlands. On this same day, Wingstop reiterated its intentions to expand into Thailand, Italy and Ireland. The first Wingstop in Australia opened on May 17, 2025. The first Dutch outlet opened on August 8 2025, at Amsterdam Airport Schiphol. The first Irish outlet on December 8, 2025 at Dublin's Liffey Valley shopping centre. On December 13, 2025, Wingstop entered the Thailand market, in MBK Center.
Eggshells, snail shells and most seashells are predominantly calcium carbonate and can be used as industrial sources of that chemical. Oyster shells have experienced recognition as a source of dietary calcium since the early 2010s, but also remain a practical industrial source. Dark green vegetables such as broccoli and kale contain dietarily significant amounts of calcium carbonate, but they not practical as an industrial source. Annelids in the family Lumbricidae, earthworms, possess a regionalization of the digestive track called calciferous glands, Kalkdrüsen, or glandes de Morren, that processes calcium and CO2 into calcium carbonate, which is later excreted into the dirt. The function of these glands is unknown but is believed to serve as a CO2 regulation mechanism within the animals' tissues. This process is ecologically significant, stabilizing the pH of acid soils.
Sources: en.wikipedia.org
Oligonucleotide synthesis is carried out by a stepwise addition of nucleotide residues to the 5'-terminus of the growing chain until the desired sequence is assembled. Each addition is referred to as a synthesis cycle (Scheme 5) and consists of four chemical reactions:
== Bibliography == Lytle, Charles F.; Meyer, John R. (May 21, 2004). General Zoology Laboratory Guide (Fourteenth ed.). New York: McGraw-Hill. ISBN 978-0-07-234900-9. Müller, Werner E.G. (February 2003). "The Origin of Metazoan Complexity: Porifera as Integrated Animals". Integrative and Comparative Biology. 43 (1): 3–10. CiteSeerX 10.1.1.333.3174. doi:10.1093/icb/43.1.3. JSTOR 3884834. PMID 21680404. {{cite journal}}: Cite uses deprecated parameter |citeseerx= (help)
Societal views, influenced by tradition, a lack of knowledge on anatomy, or sexism, can significantly impact a person's decision to alter their own or another person's genitalia. Women may want to alter their genitalia (vagina or vulva) because they believe that its appearance, such as the length of the labia minora covering the vaginal opening, is not normal, or because they desire a smaller vaginal opening or tighter vagina. Women may want to remain youthful in appearance and sexual function. These views are often influenced by the media, including pornography, and women can have low self-esteem as a result. They may be embarrassed to be naked in front of a sexual partner and may insist on having sex with the lights off. When modification surgery is performed purely for cosmetic reasons, it is often viewed poorly, and some doctors have compared such surgeries to female genital mutilation (FGM). Female genital mutilation, also known as female circumcision or female genital cutting, is genital modification with no health benefits. The most severe form is Type III FGM, which is infibulation and involves removing all or part of the labia and the vagina being closed up. A small hole is left for the passage of urine and menstrual blood, and the vagina is opened up for sexual intercourse and childbirth.
Robert Culp at IMDb Robert Culp at the TCM Movie Database Robert Culp at the Internet Broadway Database Robert Culp at the Internet Off-Broadway Database (archived) Robert Culp at The Interviews: An Oral History of Television
=== Superintelligence and the singularity === A superintelligence is a hypothetical agent that would possess intelligence far surpassing that of the brightest and most gifted human mind. If research into artificial general intelligence produced sufficiently intelligent software, it might be able to reprogram and improve itself. The improved software would be even better at improving itself, leading to what I. J. Good called an "intelligence explosion" and Vernor Vinge called a "singularity". In Artificial Intelligence: A Modern Approach, Russel and Norvig cast doubt on the possibility of a singularity, arguing that "so far, every technology has followed an S-shaped curve", and that "sometimes it is not possible to keep the growth going."
Sources: en.wikipedia.org
It has not been approved as a therapeutic by major regulators, and the human trial record is small and dated. Material available today is mostly sold as a research chemical for laboratory use. Approval and restriction status varies by country.
It binds the ghrelin receptor, known as the growth hormone secretagogue receptor type 1a. Activation of that receptor triggers signaling that leads to growth hormone release. Selectivity for growth hormone over cortisol and prolactin is the property most often cited for this compound.
Published estimates place the circulating half-life at roughly two hours in humans. Clearance involves peptidase activity and renal handling. Because the peptide is short-lived, release patterns after administration are usually described as pulsatile rather than sustained.
Reversed-phase liquid chromatography is standard for purity, and mass spectrometry is standard for identity. Amino acid analysis is used when quantitative composition matters. No single technique answers every question, so laboratories usually combine two or three.